CASI Pharmaceuticals
CASI
#10583
Rank
HK$33.39 M
Marketcap
HK$1.63
Share price
0.00%
Change (1 day)
-89.42%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): -HK$21.61

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$21.69. In 2024 the company made an earnings per share (EPS) of -HK$20.05 a decrease over its 2023 EPS that were of -HK$15.82.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$21.617.77%
2024-HK$20.0526.73%
2023-HK$15.82-32.89%
2022-HK$23.5711.9%
2021-HK$21.07-38.44%
2020-HK$34.23-8.96%
2019-HK$37.5950%
2018-HK$25.0677.78%
2017-HK$14.105.88%
2016-HK$13.31-22.73%
2015-HK$17.23-76.09%
2014-HK$72.05318.18%
2013-HK$17.23-71.79%
2012-HK$61.0965.96%
2011-HK$36.81-50%
2010-HK$73.62-18.97%
2009-HK$90.85-63.64%
2008-HK$249.843.57%
2007-HK$241.23-60.56%
2006-HK$611.6897.22%
2005-HK$310.15-2.7%
2004-HK$318.76-45.59%
2003-HK$585.83-61.8%
2002-HK$1,534-25.52%
2001-HK$2,059-21.38%
2000-HK$2,61913.86%
1999-HK$2,300149.53%
1998-HK$921.8398.15%
1997-HK$465.2210.2%
1996-HK$422.15